PHASE I STUDY OF ABT-199 (GDC-0199) IN PATIENTS WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA: RESPONSES OBSERVED IN DIFFUSE LARGE B-CELL (DLBCL) AND FOLLICULAR LYMPHOMA (FL) AT HIGHER COHORT DOSES

被引：0
|
作者：
Davids, M. S. [1 ]
Seymour, J. F. [2 ]
Gerecitano, J. F. [3 ]
Kahl, B. S. [4 ]
Pagel, J. M. [5 ]
Wierda, W. G. [6 ]
Anderson, M. A. [7 ,8 ]
Rudersdorf, N. K. [9 ]
Gressick, L. A. [9 ]
Montalvo, N. P. [9 ]
Yang, J. [9 ]
Zhu, M. [9 ]
Dunbar, M. [9 ]
Cerri, E. [9 ]
Enschede, S. H. [9 ]
Humerickhouse, R. A. [9 ]
Roberts, A. W. [7 ,8 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[4] Univ Wisconsin, Madison, WI 53706 USA
[5] Univ Washington, Seattle, WA 98195 USA
[6] Univ Texas Houston, Houston, TX USA
[7] Royal Melbourne Hosp, Melbourne, Vic, Australia
[8] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia
[9] AbbVie, N Chicago, IL USA
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S1348
引用
收藏
页码：525 / 525
页数：1
相关论文
共 50 条
  • [31] Phase I/II study of a hybrid schedule of flavopiridol in relapsed/refractory mantle cell lymphoma (MCL) and diffuse large B-cell lymphoma (DLBCL)
    Tay, K.
    Shapiro, G.
    Disinski, M.
    Chirieac, L. R.
    Pittaluga, S.
    Jaffe, E. S.
    Janik, J. E.
    Wiestner, A.
    Wilson, W. H.
    Dunleavy, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma
    Christian, Beth A.
    Huang, Ying
    Ayyappan, Sabarish
    Baiocchi, Robert A.
    Brammer, Jonathan E.
    Epperla, Narendranath
    Jaglowski, Samantha
    William, Basem M.
    Awan, Farrukh T.
    Maddocks, Kami J.
    Blum, Kristie A.
    BLOOD, 2019, 134
  • [33] A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
    Ogura, Michinori
    Ando, Kiyoshi
    Suzuki, Tatsuya
    Ishizawa, Kenichi
    Oh, Sung Yong
    Itoh, Kuniaki
    Yamamoto, Kazuhito
    Au, Wing Yan
    Tien, Hwei-Fang
    Matsuno, Yoshihiro
    Terauchi, Takashi
    Yamamoto, Keiko
    Mori, Masahiko
    Tanaka, Yoshinobu
    Shimamoto, Takashi
    Tobinai, Kensei
    Kim, Won Seog
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (06) : 768 - 776
  • [34] Phase I study of obinutuzumab (GA101) in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma
    Ogura, Michinori
    Tobinai, Kensei
    Hatake, Kiyohiko
    Uchida, Toshiki
    Suzuki, Tatsuya
    Kobayashi, Yukio
    Mori, Masakazu
    Terui, Yasuhito
    Yokoyama, Masahiro
    Hotta, Tomomitsu
    CANCER SCIENCE, 2013, 104 (01) : 105 - 110
  • [35] Updated Results of a Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
    Christian, Beth A.
    Kuruvilla, John G.
    Smith, Sonali M.
    Porcu, Pierluigi
    Maddocks, Kami J.
    Ruppert, Amy S.
    Byrd, John C.
    Grever, Michael R.
    Blum, Kristie A.
    BLOOD, 2015, 126 (23)
  • [36] Phase I/II Clinical Trial of Ibrutinib and Buparlisib in Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma, and Follicular Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (08) : 17 - 18
  • [37] ABT-199 (GDC-0199) COMBINED WITH RITUXIMAB (R) IN PATIENTS (PTS) WITH RELAPSED / REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): INTERIM RESULTS OF A PHASE 1B STUDY
    Roberts, A. W.
    Ma, S.
    Kipps, T.
    Barrientos, J. C.
    Davids, M. S.
    Anderson, M. A.
    Tam, C.
    Mason-Bright, T.
    Rudersdorf, N. K.
    Yang, J.
    Munasinghe, W.
    Zhu, M.
    Cerri, E.
    Enschede, S. H.
    Humerickhouse, R. A.
    Seymour, J. F.
    HAEMATOLOGICA, 2014, 99 : 249 - 249
  • [38] Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
    Ohmachi, Ken
    Ando, Kiyoshi
    Ogura, Michinori
    Uchida, Toshiki
    Itoh, Kuniaki
    Kubota, Nobuko
    Ishizawa, Kenichi
    Yamamoto, Joji
    Watanabe, Takashi
    Uike, Naokuni
    Choi, Ilseung
    Terui, Yasuhito
    Usuki, Kensuke
    Nagai, Hirokazu
    Uoshima, Nobuhiko
    Tobinai, Kensei
    CANCER SCIENCE, 2010, 101 (09) : 2059 - 2064
  • [39] Phase II study of single-agent copanlisib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
    Lenz, Georg
    Hawkes, Eliza
    Verhoef, Gregor
    Haioun, Corinne
    Thye, Lim Soon
    Heo, Dae Seog
    Ardeshna, Kirit
    Chong, Geoffrey
    Christensen, Jacob Haaber
    Shi, Vivian
    Lippert, Susanne
    Niemeyer, Florian
    Piraino, Paolo
    Pena, Carol Elaine
    Buvaylo, Viktoriya
    Childs, Barrett H.
    Gorbatchevsky, Igor
    Salles, Gilles A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Kalakonda, Nagesh
    Cavallo, Federica
    Follows, George
    Goy, Andre
    Vermaat, Joost S. P.
    Casasnovas, Olivier
    Lavee, Orly
    Maerevoet, Marie
    Zijlstra, Josee
    Bakhshi, Sameer
    Bouabdallah, Reda
    Choquet, Sylvain
    Gurion, Ronit
    Hill, Brian
    Jaeger, Ulrich
    Sancho, Juan-Manuel
    Schuster, Michael
    Thieblemont, Catherine
    De la Cruz, Fatima
    Egyed, Miklos
    Mishra, Sourav
    Offner, Fritz
    Vassilakopoulos, Theodoros
    Warzocha, Krzysztof
    McCarthy, Daniel
    Ma, Xiwen
    Corona, Kelly
    Saint-Martin, Jean-Richard
    Joshi, Anita
    Shah, Jatin
    Van den Neste, Eric
    Canales, Miguel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S248 - S249
12345